Dr. Federico Laurel Ampil, MD

Dr. Ampil practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Dr. Ampil's NPI, 1538185012, was assigned on July 15, 2006. Dr. Ampil holds Louisiana license MD.06280R.

Dr. Ampil's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Dr. Ampil's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Dr. Ampil is also affiliated with Ochsner LSU Health - St. Mary Medical Center. The medical group on file is LSU Health Shreveport.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ampil practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ampil's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ampil is licensed in Louisiana.

Dmand AI lists breast cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Ampil treats.

CMS data shows 466 Medicare services from Dr. Ampil across 5 procedure codes in 2024, for 43 Medicare patients. Medicare paid $15,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 43 Medicare patients who saw Dr. Ampil in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ampil's median patient age at 69, with 33% women.

Dr. Ampil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 162 papers to Dr. Ampil, published from 2004 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Head and Neck Neoplasms, Lung Neoplasms and Palliative Care. Dr. Ampil has published most often in Oral Oncol. Dr. Ampil's most frequent co-authors are Glenn Morris Mills, MD, Cherie-Ann Olympia Nathan, MBBS and Ghali Elias Ghali, DDS, MD.

CMS Open Payments shows 7 general payments to Dr. Ampil from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Elekta, Inc. paid the most, $115.

Dr. Ampil is in network with 6 carriers, including United Healthcare, HCSC and Humana. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.